RecruitingNot ApplicableNCT06589297

Body Composition and Acute Stroke

Prognostic Value for Predicting Functional Outcome Bioimpedancemetry and Temporal Muscle Measurement in Acute Stroke


Sponsor

Centre Hospitalier Régional d'Orléans

Enrollment

250 participants

Start Date

Oct 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Body composition appears to be a prognostic factor for the severity and functional outcome of stroke patients. In this study the prognostic value of two bioimpedance parameters will be studied (skeletal mass index and phase angle) and two temporal muscle measurements (thickness and surface area) to predict the functional outcome of patients at discharge and at 6 months


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • volunteer stroke patients in acute phase
  • Age ≥ 18 years
  • Having had a brain MRI
  • Able to understand assessment guidelines
  • Not having objected to participate in the study after being duly informed

Exclusion Criteria5

  • Person under tutorship or curatorship
  • Person under court protection
  • Persons deprived of their liberty
  • Pregnant or breastfeeding women
  • Have a pacemaker or defibrillator

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTModified Rankin scale

Acute stroke patients will undergo modified rankin scale


Locations(1)

CHU d'ORLEANS

Orléans, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06589297


Related Trials